[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369505-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369505-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","inhibiting-nhej-in-hnscc-cell-lines-by-the-ligase-iv-inhibitor-scr130-has-limited-radiosensitizing-effects","Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects","","Radiotherapy is an important treatment for head and neck squamous cell carcinoma (HNSCC), yet radioresistance limits outcomes due to altered DNA damage response (DDR). The study evaluates whether inhibiting non-homologous end joining (NHEJ) with the ligase IV inhibitor SCR130 can sensitize HNSCC cells to ionizing radiation (2 Gy). HNSCC and healthy fibroblast cell lines were treated with 30 µM SCR130 plus radiation, showing only limited, highly cell line–specific effects on cell death, clonogenicity, and DNA damage. SCR130 also increased G0/G1 cells with p21 expression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inhibiting-nhej-in-hnscc-cell-lines-by-the-ligase-iv-inhibitor-scr130-has-limited-radiosensitizing-effects/369505/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inhibiting-nhej-in-hnscc-cell-lines-by-the-ligase-iv-inhibitor-scr130-has-limited-radiosensitizing-effects/369505.png","ImageObject",300,407,{"name":42,"@type":43},"Alex Sinclair","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why target DDR and NHEJ in HNSCC radiosensitization?","Question",{"text":63,"@type":64},"Radioresistance in HNSCC limits radiotherapy success, and it is influenced by DNA damage response. Inhibiting NHEJ is proposed to specifically target tumor cells while sparing healthy tissue that can use alternative DSB repair pathways.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were SCR130 and ionizing radiation applied in the experiments?",{"text":68,"@type":64},"HNSCC and healthy fibroblast cell lines were treated with 30 µM SCR130 and a single 2 Gy dose of ionizing radiation to assess radiosensitizing effects.",{"name":70,"@type":61,"acceptedAnswer":71},"What was the overall effect of SCR130 combined with radiation?",{"text":72,"@type":64},"The combination produced limited radiosensitization, highly dependent on the cell line, with restrained effects on cell death, clonogenicity, and DNA damage. SCR130 consistently increased G0/G1 phase cell numbers along with p21 expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369505,1790613257,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523882182,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nInhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects  \nLaura S. Hildebrand1,2, Tina Jost2,3, Marion Schindler4, Anja Derer2,3, Gregor Fuhrmann4, Rainer Fietkau1,2 & Luitpold V. Distel1,2􀀍  \nRadiotherapy (RT) is a relevant treatment for head and neck squamous cell carcinoma (HNSCC) patients but radioresistance, which depends on DNA damage response (DDR), restrains outcome. Therefore, manipulating DDR by small molecule inhibitors (SMI) is a promising treatment option. The main DNA double strand break (DSB) repair mechanisms in healthy mammalian cells are homologous recombination (HR) and non-homologous end joining (NHEJ) . It is known that HR is already often impaired in tumors because of cancerous transitions. Therefore, additionally inhibiting NHEJ is a possibility to specifically target tumor cells and spare healthy tissue, which has the alternative DSB repair mechanism available. We treated HNSCC and healthy fibroblast cell lines with 30 µM of the ligase IV inhibitor SCR130 and a single dose of 2 Gy (Gy) ionizing radiation (IR) to investigate the inhibitor’s radiosensitizing effect. In short, the effect of SCR130 in combination with IR on cell death, clonogenicity, and DNA damage is limited and highly cell line specific. Nevertheless, SCR130 increases the number of cells in G0/G1 phase concomitant with gained p21 expression consistently. We suggest that SCR130 in combination with IR has anti-proliferative effects, but an escape of the cells by upregulation of ligase IV resulting from the treatment is possible.  \nKeywords Ligase IV, SCR130, Head and neck squamous cell carcinoma, DNA damage response, Radiation sensitivity, Ionizing radiation  \nAbbreviations  \nABCB1 ATP binding cassette subfamily B member 1  \nABCG2 ATP binding cassette subfamily G member 2 ACTB Actin beta  \nAPC Allophycocyanin  \nATM Ataxia telangiectasia mutated  \nATR Ataxia telangiectasia and Rad3-related protein  \nBSA Bovine serum albumin  \nCardiolipin 18:1 1’,3’-bis[1,2-dioleoyl-sn-glycero-3-phospho]-glycerol CDKN1A Cyclin dependent kinase inhibitor 1 A  \nCDKN2A Cyclin dependent kinase inhibitor 2 AcDNA Complementary DNA  \nCHEK1 Checkpoint kinase 1  \nC12FDG 5-Dodecanoylaminofluorescein Di-β-D-Galactopyranosid DAPI 2-(4-Amidinophenyl)-1 H-indole-6-carboxamidine DMSO Dimethyl sulfoxide  \nDDR DNA damage response  \nDNA-PKcs DNA-dependent protein kinase catalytic subunit DOPG 18:1 1,2-dioleoyl-sn-glycero-3-phospho-(1’-rac-glycerol) DPBS Dulbecco’s phosphate buffered saline  \nDSB Double strand break  \n1Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg (FAU), Universitätsstraße 27, 91054 Erlangen, Germany. 2Comprehensive Cancer Center ErlangenEMN (CCC ER-EMN), Erlangen, Germany. 3Department of Radiation Oncology, Translational Radiobiology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Universitätsstraße  \n27, 91054 Erlangen, Germany. 4Department of Biology, Pharmaceutical Biology, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Staudtstraße 5, 91058 Erlangen, Germany. 􀀍 email: [luitpold.distel@uk-erlangen.de](luitpold.distel@uk-erlangen.de)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nEDTA  \nFBS  \ngDNA  \nGy  \nHMBSHNSCC HPV  \nHR  \nIR  \nKu70/Ku80 LIG4  \nmTOR  \nNHEJ  \nNTA  \nNTC  \nPAXX  \nPE qRT-PCR RAD51 RT  \nSF  \nSMI  \nTBS  \nXLFXRCC4 7AAD  \nEthylenediaminetetraacetic acid  \nFetal bovine serum Genomic DNA Gray  \nHydroxymethylbilane synthase  \nHead and neck squamous cell carcinoma Human papilloma virus  \nHomologous recombination Ionizing radiation  \nDimeric Ku70/Ku80 protein complex DNA ligase 4  \nMechanistic target of rapamycin kinase  \nNon-homologous end joining Nanoparticle tracking analyzer No template control Paralog ofXRCC4 and XLF Plating efficiency  \nQuantitative real-time polymerase c","cbCair0CTYGbGY5b","https://ap.wps.com/l/cbCair0CTYGbGY5b","pdf",4121983,18,"English","# Introduction\n## Rationale for targeting DDR and NHEJ\n# Methods\n## SCR130 and ionizing radiation treatment setup\n# Results\n## Limited, cell line–specific radiosensitization effects\n# Discussion\n## Anti-proliferative effects and potential escape via ligase IV upregulation","[{\"question\":\"Why target DDR and NHEJ in HNSCC radiosensitization?\",\"answer\":\"Radioresistance in HNSCC limits radiotherapy success, and it is influenced by DNA damage response. Inhibiting NHEJ is proposed to specifically target tumor cells while sparing healthy tissue that can use alternative DSB repair pathways.\"},{\"question\":\"How were SCR130 and ionizing radiation applied in the experiments?\",\"answer\":\"HNSCC and healthy fibroblast cell lines were treated with 30 µM SCR130 and a single 2 Gy dose of ionizing radiation to assess radiosensitizing effects.\"},{\"question\":\"What was the overall effect of SCR130 combined with radiation?\",\"answer\":\"The combination produced limited radiosensitization, highly dependent on the cell line, with restrained effects on cell death, clonogenicity, and DNA damage. SCR130 consistently increased G0/G1 phase cell numbers along with p21 expression.\"}]","Inhibiting NHEJ in HNSCC cell lines by the ligase IV inhibitor SCR130 has limited radiosensitizing effects | PDF",1790183118,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/229f65d6038fdd969e0748abd1f677c4.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79aa8811e69554bae41bebda0efde502.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/788772e93ee54e538563df768fe442f0.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b7875d892c9a9e22a6a5b6551980617.webp",980,1287]